Table 2 Hospitals describing their largest outbreak
| Â | Total | 2018 | 2019 |
|---|---|---|---|
Total number of outbreaks | 10 | 5 | 5 |
Median duration of outbreak in weeks (IQR) | 14 (6.5–37.0) | 8 (4–58) | 20 (12–43) |
Involved wards | |||
ICU, n (%) | 3 (20.0) | 1 (13.0) | 2 (29.0) |
Surgical ward, n (%) | 3 (20.0 | 2 (25.0) | 1 (14.0) |
Hemato-oncology, n (%) | 2 (13.3) | 1 (13.0) | 1 (14.0) |
Internal medicine, n (%) | 3 (20.0) | 2 (25.0) | 1 (14.0) |
Neonatology, n (%) | 2 (13.3) | 2 (25.0) | 0 |
Geriatric ward, n (%) | 1 (6.7) | 0 | 1 (14.0) |
Several wards (not specified), n (%) | 1 (6.7) | 0 | 1 (14.0) |
Involved VRE cases, median (IQR) | 11 (7–28) | 11 (6–274) | 12 (7–38) |
Total VRE cases | 671 | 570 (85.0) | 101 (15.0) |
VRE bacteremias, n (%) | 15 (2.2) | 10 (2.0) | 5 (5.0) |
VRE infection, n (%) | 29 (4.3) | 15 (3.0) | 14 (14.0) |
VRE detected by screening, n (%) | 627 (93.4) | 545 (96.0) | 82 (81.0) |
Teicoplanin-resistant VRE isolates, n (%) | 91 (13.4) | 71 (12.0) | 20 (19.0) |
Teicoplanin-susceptible VRE isolates, n (%) | 588 (86.6) | 502 (88.0) | 86 (81.0) |